PANW Palo Alto Networks CEO Nikesh Arora filed last week for a $10M purchase executed March 27. The $147B cybersecurity chief bought 67,985 shares showing rare insider confidence. The filing landed same-day demonstrating transparency.
RA Capital Management dominated biotech buying. WVE Wave Life Sciences absorbed $54.6M across four separate transactions through March 30. The investment firm accumulated 8.8M shares as the genetic medicine company traded near $6.
PHR Phreesia grabbed $9.6M from Pale Fire Capital across two buys. The healthcare tech platform attracted private equity conviction. MLYS Mineralys Therapeutics pulled $8.8M from RA Capital showing continued biotech appetite.
Selling dominated executive activity. AROC Archrock CFO Douglas Aron dumped $5.9M across two March transactions filed March 31. WLK Westlake CFO Mark Bender sold $1.8M March 27.
ANVS Annovis Bio Chairman Michael Hoffman bought $1.5M filing April 3. The Alzheimer's biotech saw rare board conviction.
Institutional buyers concentrated positions while executives systematically exited.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
